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Massive pulmonary embolism is associated with significant perioperative morbidity and mortality.  We report here 
on a case of a 69-year-old man who suffered a massive pulmonary embolism with pulseless electrical activity during 
knee arthroscopic surgery.  After a diagnosis was made by performing transthoracic echocardiography, the patient 
was treated with recombinant tissue-type plasminogen activator.  The patient was transferred to the intensive care 
unit after his hemodynamic status improved.  The patient went on to make a full cardiopulmonary recovery without 
any complications.  (Korean J Anesthesiol 2010; 59: 56-60)
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    Intraoperative acute pulmonary thromboembolism is a 
devastating condition that has a very high risk of mortality, 
and it requires prompt diagnosis and treatment. However, this 
condition is difficult to diagnose when the patient is under 
general anesthesia due to the nonspecific clinical findings and 
the lack of signs. Treatment should be started immediately 
since severe pulmonary embolism leads to rapid hemodynamic 
deterioration. Although thrombolysis is widely accepted as the 
front-line therapy for most patients with massive pulmonary 
embolism, the treatment fails in 15-20% of patients [1]. Surgical 
embolectomy has been reserved for the severely compromised 
patients or for those in whom thrombolytic therapy has failed. 
However, the mortality after surgical embolectomy remains at 
approximately 27% [2]. 
    Here we report on a case of massive pulmonary embolism 
that occurred during general anesthesia, and the patient was 
successfully treated with alteplase, a recombinant tissue-type 
plasminogen activator (r-tPA). 
Case Report
    A 69-year-old man (height, 170 cm; weight, 80 kg) was 
scheduled for repeated arthroscopic lavage of the right knee 
for the treatment of unimproved septic arthritis in spite of 57 www.ekja.org
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the previous procedure that had been carried out 2 weeks 
previously. At the evaluation done 2 weeks ago, it was found 
that he had peripheral arterial occlusive disease in the lower 
extremities, but there was no evidence of deep vein thrombosis. 
He was being treated for hypertension and type 2 diabetes. 
During the first arthroscopic lavage under general anesthesia, 
new onset atrial fibrillation with a rapid ventricular response 
was noted. The transthoracic echocardiography done at that 
time showed left atrial enlargement, normal left ventricular 
function with an ejection fraction of 61.3% and there was no 
evidence of intracardiac thrombus. Flecainide and aspirin were 
prescribed for the atrial fibrillation. 
    Before the second operation, the preoperative electro  car    dio-
gram showed normal sinus rhythm. Intramuscular injection of 
glycopyrrolate 0.2 mg was given as premedication. Anesthesia 
was induced with propofol and rocuronium and the airway 
was secured with a cuffed 7.5 mm endotracheal tube. The 
electrocardiogram, pulse oxygen saturation, capnogram and 
esophageal temperature were monitored. The invasive arterial 
pressure was also monitored because the vital signs were 
unstable during the previous operation due to atrial fibrillation 
and the septic condition. Anesthesia was maintained with 
sevoflurane and 50% nitrous oxide in oxygen. Arterial blood gas 
analysis that was done 10 minutes after induction of anesthesia 
showed pH 7.38, PaCO2 45.1 mmHg, PaO2 85.7 mmHg, HCO3
- 
26.0 mEq/L and SaO2 95.5% (FiO2: 0.5). The end tidal CO2 was 24 
mmHg. The tidal volume was increased to 750 ml from 650 ml. 
Twenty minutes after changing the ventilator setting, arterial 
blood gas analysis showed pH 7.31, PaCO2 47.0 mmHg, PaO2 
75.1 mmHg, HCO3
- 23.6 mEq/L and SaO2 92.8% (FiO2: 0.5).
    Phenylephrine 100 μg was injected intravenously at 30 
minutes after induction because the blood pressure started to 
drop to 90/60 mmHg and the heart rate increased to 100 beats 
per minute. Forty minutes after anesthetic induction when the 
surgical procedure was almost completed, the arterial blood 
pressure dropped to 65/45 mmHg with a heart rate of 48 beats 
per minute. Epinephrine 30 μg and then an additional 50 
μg of peinephrine and atropine sulfate 0.5 mg were injected 
intravenously. However, the vital signs deteriorated and the 
pulsatile activity disappeared in the arterial line. Cardio-
pulmonary resuscitation (CPR) was immediately started and 
the surgery was completed. The nitrous oxide and sevo  flurane 
were turned off. Epinephrine 1 mg and atropine sulfate 0.5 
mg were administered intravenously. The vital signs were not 
improved in spite of intermittent administration of epinephrine. 
The arterial blood gas analysis showed pH 7.37, PaCO2 27.8 
mmHg, PaO2 63.9 mmHg, HCO3
- 15.8 mEq/L and SaO2 90.8% 
(FiO2: 1.0). 
    Eight minutes after starting CPR, external cardiac massage was 
stopped because the vital signs were restored. Arterial blood gas 
analysis showed pH 6.96, PaCO2 63.9 mmHg, PaO2 221.4 mmHg, 
HCO3
- 13,9 mEq/L and SaO2 98.5% (FiO2: 1.0). Thereafter, with 
the vital signs fluctuating severely, the CPR was intermittently 
continued with the administration of epinephrine and sodium 
bicarbonate on the basis of the hemodynamic status and the 
results of the arterial blood gas analysis. Ten minutes after 
initiation of CPR, an emergency transthoracic echocardiogram 
was performed with the impression of pulmonary embolism 
and it showed a massive amount of thrombus in the right atrium 
and a dilated hypokinetic right ventricle with a D shaped left 
ventricle (Fig. 1). Under the preliminary diagnosis of massive 
pulmonary embolism, the decision was made to proceed with 
fibrinolysis while the CPR was ongoing. Thirty-seven minutes 
after the initiation of CPR, 20 mg of alteplase, which is a r-tPA 
(Actylase
Ⓡ, Boehringer Ingelheim, Ingelheim, Germany), was 
administered intravenously and 100 mg was continuously 
infused over 90 minutes. The echocardiogram after injection of 
r-tPA showed improvement of the D shaped left ventricle, but 
multiple, mobile thrombi in the right atrium were still present 
(Fig. 2). The hemodynamic performance of the systemic and 
Fig. 1. (A) Transthoracic echocardio-
graphy shows multiple, mobile hyper-
echoic thrombi (arrows) in the right 
atrium (RA) and marked dilatation of 
the RA and right ventricle (RV). (B) The 
shifted interventricular septum to the 
left ventricular (LV) side (D-shaped left 
ventricle) during diastole, as seen on 
the parasternal short axis view. LA: left 
atrium.58 www.ekja.org
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pulmonary circulation was stabilized. There was no sign of 
bleeding at the operation site. The external cardiac massage was 
stopped 26 minutes after injecting the recombinant tissue-type 
plasminogen activator. The patient, who was in an intubated 
state, was transferred to the intensive care unit. As the patient 
was transferred to the intensive care unit, the blood pressure 
increased to 110/60 mmHg and the heart rate was 100 beats 
per minute, with mechanical ventilation. Heparin was given 
12 hours after injecting the r-tPA. The PT was INR was 1.65 and 
the aPTT was 50-70 seconds. Eighteen hours later, the patient’s 
consciousness became alert and the endotracheal tube was 
extubated. 
    The thrombi had completely disappeared and the dilated 
hypokinetic right ventricle had returned to normal, as was 
noted on the echocardiogram performed 3 days after surgery 
(Fig. 3). The heparin infusion was stopped 5 days after surgery 
and patient recovered completely without any hemorrhagic 
episodes. He was transferred from the intensive care unit to the 
medical ward. 
Discussion
    The representative therapeutic modalities for treating pulmo-
nary embolism include medical treatment with thrombolytics 
and surgical measures. Although massive pulmonary embolism 
that causes hemodynamic instability has generally been treated 
with surgical embolectomy, it seems that fibrinolytic agents are 
now being increasingly advocated as the first line therapy for 
such a condition [3]. 
    As the causes of perioperative pulmonary embolism, 80 to 
90% of it originates from deep vein thrombosis and only 71% of 
these patients can survive over 1 week [4]. Prolonged immobility, 
obesity and an age more than 60 years are considered to be 
additional risk factors for pulmonary thromboembolism. 
Even though there was no evidence of deep vein thrombosis 
2 weeks before surgery, such risk factors for pulmonary 
thromboembolism as an older age, 2 weeks of immobilization 
and obesity were all present in this current case. Therefore, we 
suspected deep vein thrombosis to be the cause of the patient’s 
Fig. 2. (A) The remaining multiple, 
mobile thrombi (arrows) in the right 
atrium (RA) after thrombolysis, as 
seen on the apical four chamber view. 
(B) Improvement of the D-shaped left 
ventricle (LV) after thrombolysis, as 
seen on the parasternal short axis view. 
RV: right ventricle, LA: left atrium.
Fig. 3. (A) The follow-up transthoracic 
echocardiography after 3 days. There 
are no visible intracardiac thrombi 
seen on the apical four chamber view. 
(B) The sizes of the ventricles are 
normalized, as seen on the parasternal 
long axis view. RA: right atrium, RV: 
right ventricle, LA: left atrium, LV: left 
ventricle, AO: aorta.59 www.ekja.org
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pulmonary thromboembolism. 
    Cyanosis, hypoxemia, hypotension, pulmonary hypertension 
and an increased central venous pressure are signs of pulmonary 
embolism during general anesthesia [4]. Wheezing in the 
breathing sounds can be heard and decreased lung compliance 
is observed. Nonspecific findings such as sudden hypocapnia 
with hypotension may be a sign of pulmonary embolism. An 
echocardiogram can be performed in an emergency situation 
for making the diagnosis of pulmonary embolism. This is 
useful to monitor the intracardiac structures and the size, 
shape and motility of the intracardiac thrombi. The presence of 
pulmonary thromboembolism can be highly suspected when 
observing dilatation of the right atrium and right ventricle, 
a shifted interventricular septum to the left ventricular side 
(D-shaped left ventricle) and pulmonary hypertension [5]. 
Echocardiography has emerged not only as a diagnostic tool for 
the detection of right heart thrombi associated with pulmonary 
embolism, but also as an aid for monitoring the effects of 
treatment and detecting possible complications [5].
    The treatment of pulmonary thromboembolism is still 
controversial. In this case, the massive pulmonary embolism 
that caused pulseless electrical activity was successfully treated 
with thrombolytic therapy. Catastrophic bleeding can occur 
with thrombolytic therapy. In a series of 312 patients who 
received thrombolytic therapy for pulmonary embolism, there 
was a 1.9% incidence of intracranial bleeding [6]. In another 
study including 132 consecutive patients received alteplase for 
massive pulmonary embolism, both intracranial bleeding and 
pericardial tamponade occurred with an incidence of 1.5% [7].
Other major bleeding complications included gastrointestinal 
hemorrhage, hemoptysis and hematomas at the puncture site 
for pulmonary angiography. Autopsy studies have shown that 
hemorrhagic complications can be estimated to occur in more 
than 15% of all patients who are undergoing thrombolysis 
after CPR [7]. Despite complications such as intracranial 
hemorrhage, thrombolysis remains the treatment of choice 
for the majority of these patients. Our patient was fortunate 
enough to make a full neurological and cardiopulmonary 
recovery without any complications. A review of 34 patients 
who were given thrombolytic agents during CPR for massive 
pulmonary embolism suggested an initial survival rate of 55-
100% [7]. By far, the most common thrombolytic drugs that 
have been used to thrombolyse pulmonary embolism are 
urokinase, streptokinase and alteplase [8]. Alteplase is currently 
the recommended drug because streptokinase may exacerbate 
hypotension, while the dose for urokinase treatment is too low 
for use in patients with pulmonary embolism [9]. The patients 
treated with alteplase infusions had a significantly lower 
mortality rate and significantly fewer major bleeding episodes 
than did the patients who were treated with streptokinase [9]. 
Once bound to fibrin clots, alteplase has a short duration of 
action, with a plasma half-life of 4-5 minutes. The fibrinolytic 
therapy action of alteplase will continue at the site of fibrin-
bound plasminogen [10]. The recommended dose of alteplase 
is 100 mg as a peripheral IV infusion over 2 hours, although 
considerable variation in the dosing has reported by several 
investigators [11].
    Apart from thrombolysis, surgical intervention and the 
combination of mechanical catheter fragmentation and 
subsequent lysis represent specific therapeutic options during 
CPR. However, they may only be effective for treating central 
pulmonary embolism. Acute surgical embolectomy during CPR 
is only an alternative in those hospitals where the patient can 
be placed on an extracorporeal bypass system. This approach 
is usually successful if it is undertaken in patients with stable 
hemodynamics [12]. Surgical embolectomy is associated 
with a maximal survival rate of 20 to 55% during CPR [13,14]. 
These techniques also may be an alternative after unsuccessful 
thrombolytic treatment and CPR [14]. 
    Our case had an episode of massive pulmonary embolism 
and this was accompanied by cardiac arrest that required CPR. 
The prognosis of patients with life-threatening pulmonary 
embolism can be significantly improved with an early diagnosis 
and starting treatment without delay [4]. In our opinion, we 
should have detected the pulmonary embolism earlier so that 
thrombolysis could have been initiated at an earlier time. A high 
clinical suspicion of impending pulmonary thromboembolism, 
according to the signs of hypoxemia, sudden hypocapnia and 
hypotension, is mandatory for diagnosing the susceptible 
patients who have risk factors for pulmonary embolism, such 
as prolonged immobility, obesity and old age, and these risk 
factors were already present in our patient. Early initiation of 
thrombolytic therapy is essential and this should be done in any 
patient with pulmonary thromboembolism, except if there is an 
absolute contraindication. This case provides further evidence 
that thrombolytic therapy may be beneficial for patients with 
pulmonary embolism that has induced cardiac arrest. 
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